Literature DB >> 7285485

Elevation of steady-state diazepam levels by cimetidine.

U Klotz, I Reimann.   

Abstract

The effect of cimetidine (1000 mg/day) on steady-state diazepam (5 mg/day) kinetics was investigated in six healthy subjects. During placebo-controlled treatment for 11 days, trough steady-state plasma levels were 130 +/- 33 ng/ml and steady-state concentration averaged 185 +/- 57 ng/ml (mean +/- SD). During concomitant treatment with diazepam and cimetidine these concentrations rose to 194 +/- 52 ng/ml and 255 +/- 46 ng/ml (P less than 0.002). The 40% to 50% increase was due to reduction (P = 0.026) of total body clearance from 20.9 +/- 9.5 ml/min (control) to 14.0 +/- 3.0 ml/min (with cimetidine). Diazepam elimination half-life was also prolonged (P = 0.02, from 39.5 +/- 16.6 hr to 101 +/- 58.1 hr) by cimetidine.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7285485     DOI: 10.1038/clpt.1981.196

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  13 in total

1.  Voriconazole and fluconazole increase the exposure to oral diazepam.

Authors:  Teijo I Saari; Kari Laine; Leif Bertilsson; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2007-08-04       Impact factor: 2.953

2.  Drug interactions through binding to cytochrome p 450: the experience with h2-receptor blocking agents.

Authors:  U Klotz; I W Reimann
Journal:  Pharm Res       Date:  1984-03       Impact factor: 4.200

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

4.  Effect of ranitidine on the steady state pharmacokinetics of diazepam.

Authors:  U Klotz; I W Reimann; E E Ohnhaus
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Effect of age and liver cirrhosis on the pharmacokinetics of nitrazepam.

Authors:  R Jochemsen; B R Van Beusekom; P Spoelstra; A R Janssens; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

6.  Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide.

Authors:  U Klotz; P Arvela; B Rosenkranz
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  The effect of intravenous cimetidine on the absorption of orally administered diazepam and lorazepam.

Authors:  W A McGowan; J W Dundee
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 8.  Clinical significance of the cytochrome P450 2C19 genetic polymorphism.

Authors:  Zeruesenay Desta; Xiaojiong Zhao; Jae-Gook Shin; David A Flockhart
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 9.  Pharmacokinetic interactions of cimetidine 1987.

Authors:  A Somogyi; M Muirhead
Journal:  Clin Pharmacokinet       Date:  1987-05       Impact factor: 6.447

10.  The influence of cimetidine on the pharmacokinetics of 5-fluorouracil.

Authors:  V J Harvey; M L Slevin; M R Dilloway; P I Clark; A Johnston; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.